A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Conditions: Patients With Candidemia and/or Invasive Candidiasis Interventions: Drug: HRS9432; Drug: Caspofungin Acetate for Injection Sponsors: Fujian Shengdi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials